Paper
0
TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms
Authors
Shivani Handa,Yosef Riazat‐Kesh
Richard Butterfield,Ganesh Sivakumar,Sangeetha Venugopal,Erin McGovern,Jonathan Feld,Douglas Tremblay,Sebastian Elghaity-Beckley,Marina Kremyanskaya,John Mascarenhas,Blake Langlais,Gina Mazza,Daniel Nathan,Joseph Tripodi,Vesna Najfeld,Amylou Dueck,Raajit Rampal,Ronald Hoffman
+17 authors
,Bridget MarcellinoJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.